MedTrace Logo

Milk Production and Body Weight Response to Suggested Protocol in Obese Lactating Women

NCT06975527 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 72

Last updated 2025-05-16

No results posted yet for this study

Summary

This study will investigate the milk production and body weight response of both mother and the newborn to aerobic exercise in obese lactating women.

Conditions

  • Breastfeeding

Interventions

OTHER

Breastfeeding guidelines

All participants will be instructed by the following guidelines: * Hold the breast so the nipple brushes the center of the infant's lips and wait for the infant to open the mouth. * Infant's mouth should be opened wide, as with a yawn and should cover the entire areola, or a large amount of the areola. * Both breasts are used in each feeding, usually 10 to 15 minutes on the first side, followed by burping before beginning the second side. * Break suction by placing finger in the corner of infant's mouth and quickly remove breast. * Apply breast massage before breastfeeding. * The neonate is nursed shortly after birth and approximately every 2 to 3 hours thereafter for a total of 8 to 12 feedings a day. * Lactating women needs about 8 to 10 glasses of fluids per day while breastfeeding. * Caffeine consumption should be limited to 2 cups of coffee, tea or cola per day. * Lactating mother should consume a healthy diet which is varied, balanced, and natural.

OTHER

Aerobic exercise

The participants will be engaged in a supervised moderate aerobic exercise in the form of walking on a treadmill for 40 minutes/ day, 3 days/ week, for 6 weeks beginning 6:8 weeks postpartum. Each exercise session will be divided into 3 phases. The warm-up phase begins with walking at low speed (within resting heart rate) on a treadmill for 5 minutes. The active phase continues for 30 minutes at a moderate intensity of 60 to 70% of maximal heart rate (HRmax). Gradual increase and adjustment of speed will be applied for each woman according to her prescribed intensity based on HRmax. HRmax is calculated by subtracting the age from 220. The program will be terminated with 5 minutes cool-down phase, during which the treadmill speed will be gradually decreased until the heart rate resumes its resting level.

Sponsors & Collaborators

  • Cairo University

    lead OTHER

Principal Investigators

  • Afaf Botla, Professor · Cairo University

  • Dalia Kamel, Professor · Cairo University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
25 Years
Max Age
35 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-05-20
Primary Completion
2025-08-30
Completion
2025-09-10

Countries

  • Egypt

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06975527 on ClinicalTrials.gov